Jiwen Zhang

Jiwen Zhang, Ph.D. is the Chief Regulatory Officer at Renovacor. Dr. Zhang has over 20 years of regulatory affairs experience, with over 10 years specifically in the field of cell and gene therapy. Dr. Zhang has held various executive and regulatory affairs roles in the biopharma industry, including Passage Bio, Inc. and Tmunity Therapeutics, Inc.where she successfully led numerous IND filings. She also previously worked for over seven years at GE Healthcare where she was responsible for building a regulatory affairs function to support the company’s newly formed cell technology and regenerative medicine business.

Dr. Zhang received a Ph.D. in in physiology and neurobiology from Rutgers University and a BS in biology from the University of Science and Technology of China.